MYO10 and cutaneous melanoma: Next, we used the PROGgeneV2 prognostic biomarker identification tool54 to study the implications of MYO10 gene expression on overall survival of 163 melanoma patients in The Cancer Genome Atlas-Skin Cutaneous Melanoma (TCGA-SKCM) data sets.